Concepedia

Peyman Hosseinchi

PH

Statistics

Publications

8

Citations

920

H-Index

8

Active since

2017

Affiliations

University of Chicago(Current)

École Polytechnique Fédérale de Lausanne

Imperial College London

University of Illinois Chicago

Peyman Hosseinchi is an author at University of Chicago specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2017–2022

8

Publications

8

Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours

Aslan Mansurov, Jun Ishihara, Peyman Hosseinchi et al. · Nature Biomedical Engineering · 2020 · 232 citations · Full text

, , +16

Targeted antibody and cytokine cancer immunotherapies through collagen affinity

Jun Ishihara, Ako Ishihara, Koichi Sasaki et al. · Science Translational Medicine · 2019 · 186 citations · Full text

, , +17

Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events

Jun Ishihara, Kazuto Fukunaga, Ako Ishihara et al. · Science Translational Medicine · 2017 · 156 citations · Full text

, , +17

Recruitment of CD103 <sup>+</sup> dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy

John‐Michael Williford, Jun Ishihara, Ako Ishihara et al. · Science Advances · 2019 · 132 citations · Full text

, , +17

Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker

Aslan Mansurov, Peyman Hosseinchi, Kevin Chang et al. · Nature Biomedical Engineering · 2022 · 94 citations · Full text

, , +12

1–5 of 8